In our series of pHGGs, DOCK6 mutations were identified exclusively at the primary tumor in two patients (#2 and #3), conserved over time in only one patient (#1) and acquired only at relapse in patient #4, suggesting a possible involvement in progression, as already documented in literature for gastric cancer. Here, DOCK6 is linked to gastric cancer.